Related Experiment Video
Updated: Oct 27, 2025
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
10.6K
Acute liver failure in newborns
Nilgün Karadağ1, Aslı Okbay Güneş1, Güner Karatekin1
1Department of Neonatal, University of Health Sciences, Zeynep Kamil Women's and Children's Hospital, İstanbul, Turkey.
Turkish Archives of Pediatrics
|July 21, 2021
Summary
Acute liver failure in newborns is a rare but serious condition. Early diagnosis and supportive care, including specific treatments for potential causes like viral infections or metabolic diseases, are crucial for improving outcomes.
Area of Science:
- Pediatrics
- Hepatology
- Neonatology
Background:
- Acute liver failure (ALF) is a sudden loss of liver function without prior liver disease, often with encephalopathy and high mortality (55-70%).
- Neonatal ALF occurs within the first 28 days of life and is rare but life-threatening.
- Coagulopathy is a key indicator for pediatric ALF, especially post-vitamin K administration.
Purpose of the Study:
- To summarize the current understanding of acute liver failure in newborns.
- To highlight the common causes, diagnostic challenges, and critical management strategies for neonatal ALF.
- To emphasize the need for further research into factors influencing treatment and prognosis.
Main Methods:
- Literature review of studies on neonatal and pediatric acute liver failure.
- Analysis of diagnostic criteria and common etiologies.
- Discussion of current supportive and etiological treatments.
Main Results:
- Gestational alloimmune liver disease is the leading cause of ALF in newborns, followed by infections, metabolic disorders, and hemophagocytic lymphohistiocytosis.
- While the overall incidence of ALF is known, specific rates for newborns and children are not well-established.
- Prompt monitoring and urgent etiological clarification are vital for management.
Conclusions:
- Neonatal ALF requires immediate supportive care and close monitoring of vital signs.
- Life-saving interventions include acyclovir (pending herpes simplex virus exclusion) and lactose-free feeds (pending galactosemia exclusion).
- Limited studies necessitate prospective research on treatment and prognosis in neonatal ALF.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
37
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
37
01:24Liver Regeneration
3.5K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.5K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
38
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
38
01:28Esophageal Varices-II: Clinical Features and Management
193
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
193
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
45
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
45
01:20Inborn Errors of Metabolism
387
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
387